John Mendelsohn Net Worth & Insider Trades
John Mendelsohn - Director, Merrimack Pharmaceuticals Inc
What is John Mendelsohn's Net Worth?
The current estimated net worth of Merrimack Pharmaceuticals Inc's Director, John Mendelsohn, is estimated to be about $58.55K . John Mendelsohn owns about 5,000 units of Merrimack Pharmaceuticals Inc common stock. In the last 5 years at Merrimack Pharmaceuticals Inc, John Mendelsohn has sold an estimated value of $0 worth.
What is John Mendelsohn's Past Insider Trading?
John Mendelsohn's largest purchase order was 5,000 units , worth over $33.14K on December 18, 2012. In total, John Mendelsohn has made about 7 transactions over 5 years of their time at Merrimack Pharmaceuticals Inc. John Mendelsohn usually trades in May and June, with the busiest year in 2012.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
JOHN MENDELSOHN
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
Merrimack Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Gary L. Crocker | 2019 | $76,000 | $ | $19,258 | $ | $ | $95,258 |
| Richard Peters | 2019 | $383,676 | $294,891 | $ | $ | $935,369 | $1,613,936 |
| Jean M. Franchi | 2019 | $214,087 | $77,544 | $ | $ | $524,461 | $816,092 |
| Jeffrey A. Munsie | 2019 | $209,658 | $72,015 | $ | $ | $478,659 | $760,332 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1274792/000119312521126831/d97305ddef14a.htm
What are Merrimack Pharmaceuticals Inc's Past Insider Trades?
Merrimack Pharmaceuticals Inc's most recent insider trade came on August 14, 2023 by Gary L Crocker who bought 4,000 units worth $49.9K . In the last 11 years, insiders at Merrimack Pharmaceuticals Inc have sold an estimated value of $15.57M and bought an estimated value of $30.37M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Gary L Crocker, See Remarks, Michael Porter, Director, and Edward Stewart, Head Commercial .
MERRIMACK PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||